Skip to content

Drug interactions

Lomitapide + Ranolazine

Severity: Major

Lomitapide and Ranolazine: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine, a weak CYP3A4 inhibitor, can raise lomitapide exposure, increasing hepatotoxicity and gastrointestinal effects. Lomitapide may also increase ranolazine levels via P-gp inhibition.

What this interaction means in plain words

Lomitapide and Ranolazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lomitapide belongs to Cardiovascular; Ranolazine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Ranolazine inhibits CYP3A4 metabolism of lomitapide and lomitapide inhibits P-glycoprotein transport of ranolazine.

What to do

Limit lomitapide to 30 mg daily with weak CYP3A4 inhibitors, monitor liver enzymes, and consider reducing the ranolazine dose.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Lomitapide with Ranolazine?

MediHelp rates the interaction as major. Lomitapide and Ranolazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ranolazine, a weak CYP3A4 inhibitor, can raise lomitapide exposure, increasing hepatotoxicity and gastrointestinal effects. Lomitapide may also increase ranolazine levels via P-gp inhibition.

How serious is the interaction between Lomitapide and Ranolazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit lomitapide to 30 mg daily with weak CYP3A4 inhibitors, monitor liver enzymes, and consider reducing the ranolazine dose.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in